跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MST CONTINUS TABLET 30 mg - HSA Drug Approval Details
Approvals
/
HSA
/
MST CONTINUS TABLET 30 mg
Approved
THERAPEUTIC
MST CONTINUS TABLET 30 mg
BARD PHARMACEUTICALS LTD
🇸🇬 Health Sciences Authority
Approval Date
Mar 4, 1991
Approval ID
148a19382f2cb47b
Company
BARD PHARMACEUTICALS LTD
Type
Therapeutic
Approval Details
Approval Id
148a19382f2cb47b
Drug Name
MST CONTINUS TABLET 30 mg
Product Name
MST CONTINUS TABLET 30 mg
Approval Number
SIN05508P
Approval Date
1991-03-04
Registrant
MUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Licence Holder
MUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N02AA01
Atc Item Name
morphine
Pharma Manufacturer Name
MUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Company Detail Path
/organization/mundipharma-pharmaceuticals-pte-ltd
Active Ingredients
MORPHINE SULPHATE
30 mg
MORPHINE SULPHATE
30 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 4, 1991
Approval ID
148a19382f2cb47b
Type
Therapeutic
Back to HSA Approvals